Gene · 5734
Papers4,106
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,106
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Expressions of shox2, RASSF1A and PTGER4, and the relationship between their methylation and clinicopathological characteristics in patients with lung cancer. | J Med Biochem | 2025 | 40386526 | PubTator, text mining | PubMed |
| Phagocytosis is differentially regulated by LPS in M1- and M2-like macrophages via PGE2 formation and EP4 signaling. | Prostaglandins Other Lipid Mediat | 2025 | 40383415 | PubTator, text mining | PubMed |
| Correlation of dermoscopic and histopathological features in basal cell carcinoma using computerized image analysis. | Front Med (Lausanne) | 2025 | 40370729 | PubTator, text mining | PubMed |
| Structural insights into the activation of the human prostaglandin E2 receptor EP1 subtype by prostaglandin E2. | Proc Natl Acad Sci U S A | 2025 | 40366695 | PubTator, text mining | PubMed |
| Biased agonism of G protein-coupled receptors as a novel strategy for osteoarthritis therapy. | Bone Res | 2025 | 40355428 | PubTator, text mining | PubMed |
| Exceptional lines and higher-order exceptional points enabled by uniform loss. | Sci Rep | 2025 | 40348798 | PubTator, text mining | PubMed |
| Spatial mapping of the AA-PGE2-EP axis in multiple sclerosis lesions. | Acta Neuropathol | 2025 | 40299057 | PubTator, text mining | PubMed |
| Synthesis of Ethylphosphonate Curcumin Mimics: Substituents Allow Switching Between Cytotoxic and Cytoprotective Activities. | Antioxidants (Basel) | 2025 | 40298666 | PubTator, text mining | PubMed |
| Instruction multi-constraint molecular generation using a teacher-student large language model. | BMC Biol | 2025 | 40269927 | PubTator, text mining | PubMed |
| The intersection of GRK2 and PGE2 in rheumatoid arthritis: a comprehensive update on pathophysiology and treatment. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | 40261352 | PubTator, text mining | PubMed |
| Developing a risk assessment model for treatment-resistant schizophrenia: The role of niacin receptor GPR109A and prostaglandin receptors DP1, EP2, and EP4 in the niacin-induced flushing pathway. | Schizophr Res | 2025 | 40220605 | PubTator, text mining | PubMed |
| miR-526b enhances glucose metabolism in breast cancer cells, an effect reversed by targeting the COX-2/EP4 pathway. | Mol Biol Rep | 2025 | 40167847 | PubTator, text mining | PubMed |
| Hypothalamus Regulates Anabolic Metabolism of Articular Cartilage Superficial Chondrocytes through PGE2 Skeletal Interoception. | Adv Sci (Weinh) | 2025 | 40138204 | PubTator, text mining | PubMed |
| Exendin-4 improves cerebral ischemia by relaxing microvessels, rapidly increasing cerebral blood flow after reperfusion. | Basic Res Cardiol | 2025 | 40121575 | PubTator, text mining | PubMed |
| Distinct roles of PGE2 signaling via EP2 and EP4 in circulating pDCs: Implications for immune modulation in the tumor microenvironment. | J Leukoc Biol | 2025 | 40116121 | PubTator, text mining | PubMed |
| SPP1 + macrophages in colorectal cancer: Markers of malignancy and promising therapeutic targets. | Genes Dis | 2025 | 40092488 | PubTator, text mining | PubMed |
| Prostaglandin E2 alleviates inflammatory response and lung injury through EP4/cAMP/IKK/NF-κB pathway. | Biochim Biophys Acta Mol Basis Dis | 2025 | 40090625 | PubTator, text mining | PubMed |
| The Role of Prostaglandin Pathway and EP Receptors in Skin Cancer Development. | Int J Dermatol | 2025 | 40047168 | PubTator, text mining | PubMed |
| Acetylsalicylic acid aggravates anaphylaxis in a PGE2-dependent manner. | J Clin Invest | 2025 | 40026245 | PubTator, text mining | PubMed |
| A phase I dose-escalation and expansion study of RMX1002, a selective E-type prostanoid receptor 4 antagonist, as monotherapy and in combination with anti-PD-1 antibody in advanced solid tumors. | Invest New Drugs | 2025 | 39976872 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5734/papers?page=8